Rucheng Yan

发表

Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer.

Rucheng Yan, Weiwei Dai, Ruixin Wu, 2022, Cancer letters.

Melittin inhibits tumor cell migration and enhances cisplatin sensitivity by suppressing IL‐17 signaling pathway gene LCN2 in castration‐resistant prostate cancer

Rucheng Yan, Weiwei Dai, Guopeng Yu, 2023, The Prostate.

NSUN5/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion

Rucheng Yan, Zhuoyang Fan, Ruotong Tian, 2024, Proceedings of the National Academy of Sciences of the United States of America.

miRNA-182-5p promotes human bladder cancer proliferation and migration through the FOXF2/SHH axis.

Ze Zhang, Rucheng Yan, Chong Wang, 2022, Neoplasma.